Global Payments (GPN)
NYSEFinancialsSpecialty Business ServicesSnapshot 2026-07-07
$77.58+0.22%
Close 2026-07-07 · 1-day change
Reading GPN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track GPN free→NYSEFinancialsSpecialty Business ServicesSnapshot 2026-07-07
Reading GPN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track GPN free→QuarterlyIQ Insights · GPN
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. Current price $77.58. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $78 GPN trades at 26× p/e — 1.6× the 17× p/e peer median, and above its own 16× history. The market is re-rating it beyond its own range; our $69 fair value is medium-confidence here. Analysts target $65–$111. Not investment advice.
$65.00 – $111.00 (median $80.50) · 8 analysts · as of 2026-06-22
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $80.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $26.25 | — | — | Hist. CAGR | high |
| graham number | 12M | $77.09 | — | — | TTM | high |
| Mgmt guidance | 12M | $230.02 | 16.5 | 13.90 | Mgmt | high |
| Peer P/B | 12M | $187.85 | 2.1 | 89.54 | TTM | high |
| Peer P/FCF | 12M | $52.84 | 13.6 | 3.88 | TTM | high |
| Peer P/E | 12M | $48.82 | 16.5 | 2.95 | TTM | high |
| Peer P/S | 12M | $109.36 | 3.4 | 32.41 | TTM | high |
| residual income | 12M | $66.72 | — | — | TTM | high |
| Own P/E history | 12M | $46.84 | 15.9 | 2.95 | TTM | high |
| triangulated | 12M | $49.29 | 16.5 | 2.98 | Triangulated | high |
| Peer P/B | 3Y | $203.88 | 2.1 | 97.18 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $35.22 | 13.6 | 2.59 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $61.99 | 16.5 | 3.75 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $173.35 | 3.4 | 51.37 | guidance | medium |
| Own P/E history | 3Y | $59.48 | 15.9 | 3.75 | Hist. CAGR(prov.) | medium |
| Peer P/B | 5Y | $215.32 | 2.1 | 102.63 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $26.88 | 13.6 | 1.98 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $67.42 | 16.5 | 4.07 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $188.53 | 3.4 | 55.87 | guidance | high |
| Own P/E history | 5Y | $64.69 | 15.9 | 4.07 | Hist. CAGR(prov.) | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.